Literature DB >> 332641

Extracellular neuraminidase production by group B streptococci.

T W Milligan, D C Straus, S J Mattingly.   

Abstract

Neuraminidase (sialidase) activity in concentrated culture filtrates of group B streptococci was measured with bovine submaxillary mucin as substrate. Group B streptococcal neuraminidase was not active on human alpha-1 acid glycoprotein and did not show increased activity on bovine submaxillary mucin that had been O-deacetylated by alkaline treatment. The enzyme was produced in a variety of media, including a chemically defined medium (FMC; Terleckyj et al., Infect. Immun. 11:649-655, 1975) supplemented with bovine serum albumin or human serum albumin. Maximal levels of activity were present in filtrates from cells grown in a dialyzable fraction of Todd-Hewitt broth harvested during the late exponential phase of growth. Dramatic decreases were seen when filtrates from the late stationary phase were assayed. The decrease in specific activity during the stationary phase was shown to be due to proteolytic digestion of neuraminidase and not to the elaboration of an extracellular neuraminic acid aldolase.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 332641      PMCID: PMC421212          DOI: 10.1128/iai.18.1.189-195.1977

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  22 in total

1.  HYDROLYSIS OF PROTEINS AND NUCLEIC ACIDS BY LANCEFIELD GROUP A AND OTHER STREPTOCOCCI.

Authors:  R H DEIBEL
Journal:  J Bacteriol       Date:  1963-12       Impact factor: 3.490

2.  THE SENSITIVITY OF THE NEURAMINOSIDIC LINKAGE IN MUCOSUBSTANCES TOWARDS ACID AND TOWARDS NEURAMINIDASE.

Authors:  R A GIBBONS
Journal:  Biochem J       Date:  1963-11       Impact factor: 3.857

3.  THE EXTRACELLULAR GLYCOSIDASES OF DIPLOCOCCUS PNEUMONIAE. I. PURIFICATION AND PROPERTIES OF A NEURAMINIDASE AND A BETA-GALACTOSIDASE. ACTION ON THE ALPHA-1-ACID GLYCOPROTEIN OF HUMAN PLASMA.

Authors:  R C HUGHES; R W JEANLOZ
Journal:  Biochemistry       Date:  1964-10       Impact factor: 3.162

4.  Methods for the quantitative estimation of N-acetylneuraminic acid and their application to hydrolysates of sialomucoids.

Authors:  D AMINOFF
Journal:  Biochem J       Date:  1961-11       Impact factor: 3.857

5.  The sialic acids. III. Distribution and properties of animal N-acetylneuraminic aldolase.

Authors:  P BRUNETTI; G W JOURDIAN; S ROSEMAN
Journal:  J Biol Chem       Date:  1962-08       Impact factor: 5.157

6.  Protein measurement with the Folin phenol reagent.

Authors:  O H LOWRY; N J ROSEBROUGH; A L FARR; R J RANDALL
Journal:  J Biol Chem       Date:  1951-11       Impact factor: 5.157

Review 7.  Group B streptococci in human disease.

Authors:  M J Patterson; A El Batool Hafeez
Journal:  Bacteriol Rev       Date:  1976-09

8.  Cellular and humoral immune response to group B streptococci.

Authors:  P H Klesius; R A Zimmerman; J H Mathews; D H Krushak
Journal:  J Pediatr       Date:  1973-12       Impact factor: 4.406

9.  Neuraminidase activity in bacterial meningitis.

Authors:  R D O'Toole; L Goode; C Howe
Journal:  J Clin Invest       Date:  1971-05       Impact factor: 14.808

10.  Influence of macromolecular biosynthesis on cellular autolysis in Streptococcus faecalis.

Authors:  M Sayare; L Daneo-Moore; G D Shockman
Journal:  J Bacteriol       Date:  1972-10       Impact factor: 3.490

View more
  16 in total

1.  Association of elevated levels of extracellular neuraminidase with clinical isolates of type III group B streptococci.

Authors:  T W Milligan; C J Baker; D C Straus; S J Mattingly
Journal:  Infect Immun       Date:  1978-09       Impact factor: 3.441

2.  Growth and amino acid requirements of various strains of group B streptococci.

Authors:  T W Milligan; T I Doran; D C Straus; S J Mattingly
Journal:  J Clin Microbiol       Date:  1978-01       Impact factor: 5.948

3.  Factors influencing release of type III antigens by group B streptococci.

Authors:  T I Doran; D C Straus; S J Mattingly
Journal:  Infect Immun       Date:  1981-02       Impact factor: 3.441

4.  Protease production by clinical isolates of type III group B streptococci.

Authors:  D C Straus; S J Mattingly; T W Milligan; T I Doran; T J Nealon
Journal:  J Clin Microbiol       Date:  1980-09       Impact factor: 5.948

5.  Properties of a hemolysin produced by group B streptococci.

Authors:  B A Marchlewicz; J L Duncan
Journal:  Infect Immun       Date:  1980-12       Impact factor: 3.441

6.  Purification and partial characterization of neuraminidase from type III group B streptococci.

Authors:  T W Milligan; S J Mattingly; D C Straus
Journal:  J Bacteriol       Date:  1980-10       Impact factor: 3.490

7.  Association of type- and group-specific antigens with the cell wall of serotype III group B streptococcus.

Authors:  T I Doran; S J Mattingly
Journal:  Infect Immun       Date:  1982-06       Impact factor: 3.441

8.  Characterization of neuraminidases produced by various serotypes of group B streptococci.

Authors:  J G Brown; D C Straus
Journal:  Infect Immun       Date:  1987-01       Impact factor: 3.441

9.  Identification of a high-virulence clone of type III Streptococcus agalactiae (group B Streptococcus) causing invasive neonatal disease.

Authors:  J M Musser; S J Mattingly; R Quentin; A Goudeau; R K Selander
Journal:  Proc Natl Acad Sci U S A       Date:  1989-06       Impact factor: 11.205

10.  Neuraminidase production by a Streptococcus sanguis strain associated with subacute bacterial endocarditis.

Authors:  D C Straus; C Portnoy-Duran
Journal:  Infect Immun       Date:  1983-08       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.